— Know what they know.
Not Investment Advice

KRMD NASDAQ

KORU Medical Systems, Inc.
1W: +4.0% 1M: +0.7% 3M: -12.7% YTD: -26.2% 1Y: +40.3% 3Y: +5.3% 5Y: +1.0%
$4.10
-0.04 (-0.97%)
 
Weekly Expected Move ±8.4%
$3 $4 $4 $4 $5
NASDAQ · Healthcare · Medical - Instruments & Supplies · Alpha Radar Neutral · Power 52 · $188.3M mcap · 42M float · 0.345% daily turnover · Short 59% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
53.1 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -16.2%  ·  5Y Avg: -46.4%
Cost Advantage ★
61
Intangibles
59
Switching Cost
48
Network Effect
59
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. KRMD shows a Weak competitive edge (53.1/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. Negative ROIC of -16.2% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$7
Avg Target
$7
High
Based on 3 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 4Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$7.00
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-01-13 Craig-Hallum Initiated $7 +21.7% $5.75
2025-12-22 Lake Street Initiated $8 +32.7% $6.03
2025-12-17 Canaccord Genuity $3 $6 +3 +4.0% $5.77
2024-11-14 Piper Sandler Matthew O\'Brien $4 $4 -1 +13.1% $3.10
2024-07-02 Canaccord Genuity Kyle Rose Initiated $3 +33.3% $2.25
2023-01-06 Piper Sandler $3 $4 +2 +21.6% $3.70
2022-05-05 Piper Sandler Jason Bednar Initiated $3 +7.1% $2.80

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
2
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. KRMD receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-04-01 C- D+
2026-03-20 D+ C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

49 Grade D
Profitability
18
Balance Sheet
86
Earnings Quality
46
Growth
86
Value
19
Momentum
79
Safety
100
Cash Flow
27
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. KRMD scores highest in Safety (100/100) and lowest in Profitability (18/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
10.93
Safe Zone
Piotroski F-Score
5/9
Beneish M-Score
-2.88
Unlikely Manipulator
Ohlson O-Score
-6.33
Bankruptcy prob: 0.2%
Low Risk
Credit Rating
A
Score: 73.4/100
Trend: Improving
Earnings Quality
OCF/NI: -0.31x
Accruals: -10.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. KRMD scores 10.93, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. KRMD scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. KRMD's score of -2.88 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. KRMD's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. KRMD receives an estimated rating of A (score: 73.4/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-83.22x
PEG
-0.79x
P/S
4.34x
P/B
11.21x
P/FCF
1117.16x
P/OCF
280.32x
EV/EBITDA
-113.85x
EV/Revenue
4.51x
EV/EBIT
-77.88x
EV/FCF
1087.18x
Earnings Yield
-1.14%
FCF Yield
0.09%
Shareholder Yield
0.01%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. KRMD currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.010
NI / EBT
×
Interest Burden
0.902
EBT / EBIT
×
EBIT Margin
-0.058
EBIT / Rev
×
Asset Turnover
1.561
Rev / Assets
×
Equity Multiplier
1.637
Assets / Equity
=
ROE
-13.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. KRMD's ROE of -13.5% is driven by Asset Turnover (1.561), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.01 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$4.10
Median 1Y
$3.75
5th Pctile
$1.27
95th Pctile
$11.20
Ann. Volatility
67.0%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Linda Tharby,
President CEO
$398,045 $— $725,169
Donald B. Pettigrew,
former President CEO
$351,923 $— $351,923
James Beck, interim
interim CEO
$113,593 $— $325,191
Karen Fisher, Financial
ancial Officer
$250,000 $— $297,994
Manuel Marques, Operating
rating Officer
$230,000 $— $260,249

CEO Pay Ratio

2:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $725,169
Avg Employee Cost (SGA/emp): $320,258
Employees: 73

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
73
-8.8% YoY
Revenue / Employee
$563,389
Rev: $41,127,366
Profit / Employee
$-36,136
NI: $-2,637,926
SGA / Employee
$320,258
Avg labor cost proxy
R&D / Employee
$60,099
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -12.6% -18.3% -12.6% -16.0% -21.0% -21.3% -25.5% -25.2% -23.9% -24.3% -53.2% -51.3% -45.5% -46.3% -32.6% -28.5% -24.3% -20.0% -15.6% -13.5% -13.46%
ROA -11.1% -16.1% -11.2% -14.3% -18.8% -19.1% -20.7% -20.4% -19.4% -19.7% -38.8% -37.5% -33.2% -33.8% -21.8% -19.0% -16.2% -13.3% -9.5% -8.2% -8.22%
ROIC -38.3% -52.9% -47.2% -53.3% -68.3% -69.7% -45.2% -44.9% -43.3% -44.4% -60.9% -54.4% -42.4% -41.8% -45.4% -40.3% -34.1% -26.8% -18.7% -16.2% -16.16%
ROCE -12.1% -16.8% -19.3% -21.8% -27.9% -28.4% -30.5% -30.3% -29.2% -29.9% -42.8% -38.2% -29.7% -29.4% -32.2% -28.6% -24.2% -19.6% -14.4% -12.5% -12.51%
Gross Margin 58.1% 57.9% 59.0% 58.0% 51.1% 55.7% 55.5% 56.1% 56.1% 62.0% 60.3% 62.3% 65.0% 63.4% 62.9% 62.8% 63.5% 60.2% 62.6% 59.8% 59.79%
Operating Margin -25.0% -21.9% -32.6% -50.1% -55.2% -19.7% -34.2% -41.3% -46.5% -25.6% -30.6% -23.9% -14.1% -20.8% -18.0% -12.9% -3.1% -6.4% -5.0% -7.4% -7.35%
Net Margin -20.3% -18.1% -16.5% -40.6% -44.6% -15.8% -26.9% -32.6% -36.0% -19.5% -1.0% -23.6% -11.7% -19.3% -17.7% -12.1% -2.0% -7.5% -4.5% -6.9% -6.86%
EBITDA Margin -22.8% -20.0% -30.8% -48.3% -53.3% -17.6% -31.6% -38.5% -43.4% -22.5% -27.4% -21.1% -11.6% -18.0% -16.9% -10.7% -1.0% -5.5% -3.4% -5.7% -5.67%
FCF Margin -33.1% -26.9% -20.0% -18.4% -32.8% -37.2% -29.3% -36.5% -23.2% -19.1% -19.9% -4.2% -3.5% -5.3% -4.8% -5.2% -6.0% -0.4% -1.1% 0.4% 0.41%
OCF Margin -29.5% -25.2% -18.4% -14.3% -24.4% -27.6% -19.4% -28.6% -19.0% -16.2% -17.2% -2.0% -1.3% -0.5% -1.0% -0.6% -1.9% 0.8% 1.1% 1.7% 1.65%
ROE 3Y Avg snapshot only -36.68%
ROE 5Y Avg snapshot only -30.65%
ROA 3Y Avg snapshot only -24.72%
ROIC 3Y Avg snapshot only -46.88%
ROIC Economic snapshot only -9.59%
Cash ROA snapshot only 2.53%
Cash ROIC snapshot only 6.12%
CROIC snapshot only 1.54%
NOPAT Margin snapshot only -4.36%
Pretax Margin snapshot only -5.22%
R&D / Revenue snapshot only 10.61%
SGA / Revenue snapshot only 43.04%
SBC / Revenue snapshot only 3.01%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -68.98 -29.18 -29.30 -21.93 -14.91 -12.95 -18.70 -22.49 -19.40 -14.93 -8.18 -8.13 -10.32 -10.46 -29.13 -22.05 -36.63 -47.71 -101.73 -87.90 -83.217
P/S Ratio 9.76 6.00 5.69 5.26 4.49 3.71 5.81 6.61 5.35 4.30 3.94 3.68 3.94 3.91 5.25 3.33 4.49 4.53 6.52 4.63 4.343
P/B Ratio 5.70 3.49 3.66 3.50 3.11 2.75 5.17 6.13 5.02 3.93 5.52 5.30 5.96 6.15 10.51 6.95 9.84 10.53 15.74 11.75 11.206
P/FCF -29.53 -22.28 -28.48 -28.50 -13.70 -9.98 -19.79 -18.09 -23.07 -22.55 -19.80 -88.27 -112.57 -73.65 -109.29 -64.23 -75.36 -1018.33 -570.81 1117.16 1117.164
P/OCF 576.36 580.33 280.32 280.317
EV/EBITDA -45.54 -17.69 -16.60 -13.76 -9.16 -7.67 -14.67 -17.91 -15.18 -11.35 -11.20 -12.17 -18.30 -19.21 -30.17 -22.37 -38.97 -53.63 -126.89 -113.85 -113.847
EV/Revenue 8.48 4.71 4.64 4.24 3.51 2.80 5.36 6.18 4.92 3.86 3.69 3.44 3.71 3.69 5.09 3.17 4.34 4.39 6.39 4.51 4.506
EV/EBIT -40.67 -16.32 -15.50 -12.97 -8.74 -7.29 -13.87 -16.76 -14.03 -10.46 -10.25 -10.99 -16.01 -16.75 -26.55 -19.41 -32.94 -43.69 -91.22 -77.88 -77.881
EV/FCF -25.65 -17.50 -23.21 -22.98 -10.72 -7.52 -18.27 -16.91 -21.24 -20.27 -18.56 -82.52 -106.04 -69.51 -105.84 -61.16 -72.81 -986.18 -559.38 1087.18 1087.180
Earnings Yield -1.4% -3.4% -3.4% -4.6% -6.7% -7.7% -5.3% -4.4% -5.2% -6.7% -12.2% -12.3% -9.7% -9.6% -3.4% -4.5% -2.7% -2.1% -1.0% -1.1% -1.14%
FCF Yield -3.4% -4.5% -3.5% -3.5% -7.3% -10.0% -5.1% -5.5% -4.3% -4.4% -5.1% -1.1% -0.9% -1.4% -0.9% -1.6% -1.3% -0.1% -0.2% 0.1% 0.09%
Price/Tangible Book snapshot only 12.241
EV/OCF snapshot only 272.793
EV/Gross Profit snapshot only 7.330
Shareholder Yield snapshot only 0.01%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 10.24 10.24 7.79 7.79 7.79 7.79 4.28 4.28 4.28 4.28 4.55 4.55 4.55 4.55 2.66 2.66 2.66 2.66 2.44 2.44 2.439
Quick Ratio 8.37 8.37 6.51 6.51 6.51 6.51 3.36 3.36 3.36 3.36 3.77 3.77 3.77 3.77 2.27 2.27 2.27 2.27 1.99 1.99 1.990
Debt/Equity 0.01 0.01 0.02 0.02 0.02 0.02 0.16 0.16 0.16 0.16 0.22 0.22 0.22 0.22 0.24 0.24 0.24 0.24 0.21 0.21 0.205
Net Debt/Equity -0.75 -0.75 -0.68 -0.68 -0.68 -0.68 -0.40 -0.40 -0.40 -0.40 -0.35 -0.35 -0.35 -0.35 -0.33 -0.33 -0.33 -0.33 -0.32 -0.32 -0.315
Debt/Assets 0.01 0.01 0.01 0.01 0.01 0.01 0.12 0.12 0.12 0.12 0.16 0.16 0.16 0.16 0.15 0.15 0.15 0.15 0.12 0.12 0.124
Debt/EBITDA -0.06 -0.04 -0.09 -0.08 -0.06 -0.06 -0.48 -0.49 -0.52 -0.50 -0.47 -0.54 -0.71 -0.72 -0.70 -0.80 -0.97 -1.25 -1.69 -2.04 -2.042
Net Debt/EBITDA 6.89 4.83 3.77 3.30 2.55 2.51 1.22 1.25 1.31 1.28 0.75 0.85 1.13 1.14 0.99 1.12 1.36 1.75 2.59 3.14 3.140
Interest Coverage -2142.47 -1058.98 -980.47 -1256.04 -1972.76 -7369.02
Equity Multiplier 1.10 1.10 1.13 1.13 1.13 1.13 1.35 1.35 1.35 1.35 1.40 1.40 1.40 1.40 1.62 1.62 1.62 1.62 1.65 1.65 1.654
Cash Ratio snapshot only 1.083
Cash to Debt snapshot only 2.538
FCF to Debt snapshot only 0.051
Defensive Interval snapshot only 194.0 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.78 0.78 0.58 0.60 0.62 0.67 0.67 0.69 0.70 0.69 0.81 0.83 0.87 0.90 1.21 1.26 1.32 1.40 1.48 1.56 1.561
Inventory Turnover 1.83 1.91 1.50 1.57 1.70 1.84 2.00 2.10 2.08 1.95 2.39 2.36 2.34 2.41 3.92 4.08 4.32 4.68 4.79 5.14 5.142
Receivables Turnover 7.27 7.25 7.62 7.88 8.21 8.77 7.80 8.12 8.23 8.02 7.50 7.71 8.11 8.41 6.89 7.18 7.55 8.00 6.89 7.25 7.251
Payables Turnover 14.06 14.73 10.49 10.95 11.90 12.87 6.92 7.27 7.18 6.75 7.01 6.93 6.87 7.06 9.38 9.76 10.34 11.22 7.93 8.51 8.508
DSO 50 50 48 46 44 42 47 45 44 46 49 47 45 43 53 51 48 46 53 50 50.3 days
DIO 200 191 243 233 214 198 182 174 176 187 153 155 156 152 93 90 84 78 76 71 71.0 days
DPO 26 25 35 33 31 28 53 50 51 54 52 53 53 52 39 37 35 33 46 43 42.9 days
Cash Conversion Cycle 224 216 256 246 228 211 176 168 169 178 149 149 148 143 107 103 98 91 83 78 78.4 days
Fixed Asset Turnover snapshot only 5.824
Operating Cycle snapshot only 121.3 days
Cash Velocity snapshot only 4.876
Capital Intensity snapshot only 0.652
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue -21.5% -20.1% -2.8% 4.4% 20.0% 28.4% 18.8% 19.5% 16.2% 6.0% 2.2% 1.0% 4.7% 11.6% 18.0% 19.6% 19.6% 22.1% 22.2% 23.3% 23.30%
Net Income -53.2% -8.5% -2.8% -98.3% -1.6% -79.1% -89.8% -46.5% -6.4% -6.4% -58.7% -55.4% -45.0% -45.1% 55.9% 60.1% 61.6% 69.0% 56.5% 57.0% 56.98%
EPS -48.2% -8.4% -2.7% -95.1% -1.5% -76.2% -86.5% -43.9% -4.8% -5.0% -57.6% -54.7% -44.4% -44.4% 56.1% 60.3% 61.9% 69.3% 56.8% 57.3% 57.33%
FCF -2.8% -8.8% -1.7% -0.7% -18.9% -77.4% -74.3% -1.4% 17.8% 45.7% 30.6% 88.5% 84.2% 68.9% 71.5% -48.8% -1.0% 89.8% 70.9% 1.1% 1.10%
EBITDA -1.8% -2.6% -5.3% -5.0% -1.5% -75.9% -55.2% -33.9% 1.7% 1.2% 7.8% 17.3% 34.5% 37.0% 39.6% 40.0% 34.4% 48.0% 63.5% 65.6% 65.56%
Op. Income -21.4% -23.3% -4.6% -96.1% -1.3% -70.7% -53.4% -34.9% -1.4% -1.9% 4.7% 14.3% 30.8% 33.3% 37.2% 37.5% 32.1% 46.0% 57.1% 58.3% 58.33%
OCF Growth snapshot only 4.40%
Asset Growth snapshot only 3.61%
Equity Growth snapshot only 1.39%
Debt Growth snapshot only -12.37%
Shares Change snapshot only 0.83%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 7.4% 5.9% 10.6% 9.9% 9.8% 8.4% 6.4% 5.8% 3.1% 2.9% 5.7% 8.0% 13.5% 15.0% 12.7% 13.0% 13.3% 13.1% 13.8% 14.2% 14.20%
Revenue 5Y 10.8% 10.8% 13.2% 14.6% 14.0% 14.3% 12.8% 12.1% 11.5% 10.1% 10.4% 9.9% 10.0% 8.6% 7.8% 7.4% 6.5% 8.2% 11.2% 13.2% 13.19%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 6.2% 3.3% 8.4% 7.5% 5.6% 3.5% 1.1% 0.6% -1.2% -0.3% 3.8% 7.1% 14.9% 18.0% 15.7% 16.3% 17.6% 17.2% 18.5% 18.7% 18.72%
Gross Profit 5Y 9.6% 9.0% 11.7% 13.3% 12.5% 12.6% 10.6% 9.4% 9.2% 8.2% 9.1% 9.2% 9.7% 8.1% 7.5% 7.4% 6.4% 8.0% 11.4% 13.1% 13.08%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y -29.7%
Assets 3Y 62.6% 62.6% 57.6% 57.6% 57.6% 57.6% 45.0% 45.0% 45.0% 45.0% -10.7% -10.7% -10.7% -10.7% -13.0% -13.0% -13.0% -13.0% -12.7% -12.7% -12.66%
Assets 5Y 37.3% 37.3% 38.2% 38.3% 38.3% 38.3% 35.5% 35.5% 35.5% 35.5% 22.0% 22.0% 22.0% 22.0% 14.4% 14.4% 14.4% 14.4% -6.7% -6.7% -6.71%
Equity 3Y 67.7% 67.7% 59.7% 59.7% 59.7% 59.7% 40.7% 40.7% 40.7% 40.7% -17.4% -17.4% -17.4% -17.4% -22.8% -22.8% -22.8% -22.8% -18.4% -18.4% -18.36%
Book Value 3Y 59.3% 59.6% 52.8% 52.7% 52.7% 52.6% 34.6% 34.7% 35.1% 39.2% -18.6% -18.5% -18.2% -18.4% -23.5% -23.5% -23.5% -23.4% -18.8% -18.9% -18.87%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.69 0.71 0.87 0.85 0.67 0.71 0.87 0.84 0.64 0.67 0.92 0.96 0.93 0.85 0.83 0.79 0.69 0.75 0.85 0.89 0.886
Earnings Stability 0.44 0.45 0.54 0.54 0.67 0.76 0.83 0.89 0.92 0.95 0.92 0.94 0.95 0.97 0.60 0.52 0.40 0.27 0.04 0.00 0.000
Margin Stability 0.98 0.96 0.97 0.97 0.95 0.94 0.94 0.94 0.94 0.95 0.95 0.95 0.94 0.94 0.94 0.94 0.94 0.94 0.94 0.94 0.945
Rev. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.81 0.97 0.97 0.50 0.50 0.82 0.82 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness
ROE Trend -0.08 -0.12 -0.13 -0.17 -0.17 -0.13 -0.20 -0.15 -0.11 -0.10 -0.47 -0.44 -0.34 -0.35 0.11 0.15 0.15 0.21 0.36 0.35 0.350
Gross Margin Trend -0.03 -0.05 -0.04 -0.04 -0.05 -0.05 -0.05 -0.05 -0.02 0.00 0.02 0.04 0.06 0.06 0.07 0.06 0.04 0.02 0.01 -0.00 -0.004
FCF Margin Trend -0.36 -0.26 -0.16 -0.11 -0.23 -0.25 -0.16 -0.18 0.10 0.13 0.05 0.23 0.24 0.23 0.20 0.15 0.07 0.12 0.11 0.05 0.051
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 2.09 1.23 0.95 0.60 0.81 0.96 0.62 0.97 0.69 0.56 0.36 0.04 0.04 0.01 0.05 0.04 0.15 -0.08 -0.18 -0.31 -0.314
FCF/OCF 1.12 1.07 1.09 1.29 1.34 1.35 1.51 1.28 1.22 1.17 1.16 2.11 2.61 10.46 5.06 8.64 3.22 -0.57 -1.02 0.25 0.251
FCF/Net Income snapshot only -0.079
CapEx/Revenue 3.6% 1.7% 1.6% 4.2% 8.4% 9.6% 10.0% 7.9% 4.2% 2.8% 2.7% 2.2% 2.2% 4.8% 3.9% 4.6% 4.1% 1.2% 2.3% 1.2% 1.24%
CapEx/Depreciation snapshot only 0.677
Accruals Ratio 0.12 0.04 -0.01 -0.06 -0.04 -0.01 -0.08 -0.01 -0.06 -0.09 -0.25 -0.36 -0.32 -0.33 -0.21 -0.18 -0.14 -0.14 -0.11 -0.11 -0.108
Sloan Accruals snapshot only -0.033
Cash Flow Adequacy snapshot only 1.335
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio 0.0% 0.00%
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 1.7% 2.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.01%
Net Buyback Yield 0.6% 1.0% -1.6% -0.0% -0.0% -0.3% -0.3% -0.2% -0.3% -0.1% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% -0.0% -0.1% -0.1% -0.08%
Total Shareholder Return 0.6% 1.0% -1.6% -0.0% -0.0% -0.3% -0.3% -0.2% -0.3% -0.1% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% -0.0% -0.1% -0.1% -0.08%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.69 0.72 0.72 0.80 0.80 0.80 0.81 0.81 0.81 0.81 1.41 1.52 1.78 1.83 1.00 1.00 1.00 1.01 1.01 1.01 1.010
Interest Burden (EBT/EBIT) 0.98 1.00 0.91 0.92 0.94 0.94 0.99 0.98 0.97 0.96 0.95 0.95 0.93 0.93 0.94 0.92 0.93 0.94 0.91 0.90 0.902
EBIT Margin -0.21 -0.29 -0.30 -0.33 -0.40 -0.38 -0.39 -0.37 -0.35 -0.37 -0.36 -0.31 -0.23 -0.22 -0.19 -0.16 -0.13 -0.10 -0.07 -0.06 -0.058
Asset Turnover 0.78 0.78 0.58 0.60 0.62 0.67 0.67 0.69 0.70 0.69 0.81 0.83 0.87 0.90 1.21 1.26 1.32 1.40 1.48 1.56 1.561
Equity Multiplier 1.14 1.14 1.12 1.12 1.12 1.12 1.23 1.23 1.23 1.23 1.37 1.37 1.37 1.37 1.50 1.50 1.50 1.50 1.64 1.64 1.637
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.07 $-0.10 $-0.10 $-0.13 $-0.17 $-0.17 $-0.19 $-0.19 $-0.18 $-0.18 $-0.30 $-0.29 $-0.26 $-0.26 $-0.13 $-0.12 $-0.10 $-0.08 $-0.06 $-0.05 $-0.05
Book Value/Share $0.81 $0.82 $0.82 $0.82 $0.81 $0.81 $0.69 $0.69 $0.69 $0.69 $0.45 $0.45 $0.44 $0.44 $0.37 $0.37 $0.36 $0.36 $0.37 $0.37 $0.36
Tangible Book/Share $0.79 $0.80 $0.80 $0.80 $0.79 $0.79 $0.67 $0.67 $0.67 $0.67 $0.43 $0.43 $0.43 $0.43 $0.35 $0.35 $0.35 $0.35 $0.35 $0.35 $0.35
Revenue/Share $0.47 $0.48 $0.53 $0.54 $0.56 $0.60 $0.61 $0.64 $0.65 $0.63 $0.62 $0.64 $0.67 $0.70 $0.73 $0.76 $0.80 $0.84 $0.89 $0.93 $0.93
FCF/Share $-0.16 $-0.13 $-0.11 $-0.10 $-0.18 $-0.22 $-0.18 $-0.23 $-0.15 $-0.12 $-0.12 $-0.03 $-0.02 $-0.04 $-0.04 $-0.04 $-0.05 $-0.00 $-0.01 $0.00 $0.00
OCF/Share $-0.14 $-0.12 $-0.10 $-0.08 $-0.14 $-0.17 $-0.12 $-0.18 $-0.12 $-0.10 $-0.11 $-0.01 $-0.01 $-0.00 $-0.01 $-0.00 $-0.01 $0.01 $0.01 $0.02 $0.02
Cash/Share $0.61 $0.62 $0.57 $0.57 $0.56 $0.56 $0.38 $0.38 $0.38 $0.38 $0.25 $0.25 $0.25 $0.25 $0.21 $0.21 $0.21 $0.21 $0.19 $0.19 $0.19
EBITDA/Share $-0.09 $-0.13 $-0.15 $-0.17 $-0.22 $-0.22 $-0.22 $-0.22 $-0.21 $-0.21 $-0.21 $-0.18 $-0.14 $-0.13 $-0.12 $-0.11 $-0.09 $-0.07 $-0.04 $-0.04 $-0.04
Debt/Share $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.11 $0.11 $0.11 $0.11 $0.10 $0.10 $0.10 $0.10 $0.09 $0.09 $0.09 $0.09 $0.08 $0.08 $0.08
Net Debt/Share $-0.61 $-0.61 $-0.55 $-0.55 $-0.55 $-0.55 $-0.28 $-0.27 $-0.27 $-0.27 $-0.15 $-0.15 $-0.15 $-0.15 $-0.12 $-0.12 $-0.12 $-0.12 $-0.12 $-0.12 $-0.12
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 10.930
Altman Z-Prime snapshot only 17.304
Piotroski F-Score 2 2 3 3 3 3 3 3 4 4 4 4 4 4 4 4 3 4 5 5 5
Beneish M-Score -2.25 -2.54 -1.41 -1.70 -1.54 -1.46 -2.51 -2.18 -2.52 -2.63 -4.30 -4.96 -4.74 -4.77 -3.10 -2.97 -2.74 -2.74 -2.92 -2.88 -2.877
Ohlson O-Score snapshot only -6.333
ROIC (Greenblatt) snapshot only -13.02%
Net-Net WC snapshot only $0.19
EVA snapshot only $-3053621.41
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A
Credit Score 68.11 57.44 57.27 58.21 59.60 59.57 60.72 71.27 71.25 71.34 70.39 70.38 69.89 70.13 69.91 70.30 69.89 70.98 70.05 73.42 73.425
Credit Grade snapshot only 6
Credit Trend snapshot only 3.128
Implied Spread (bps) snapshot only 150.000
Industry Credit Rank snapshot only 61
Sector Credit Rank snapshot only 75

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms